Since SPTBN1 has also been shown to carry genetic alterations in hepatocellular carcinoma patients with a short OS [34], this may be a starting point for future investigations on SPTBN1 mutations in PDAC patients. This evidence concerns the gene SPTBN1 and hepatocellular carcinoma.